MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Disruptive analytics’ Substack by Magnus Ofstad. In this article ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

No adequate supply? Semaglutide (GLP-1) weight-loss drug Wegovy, made by pharmaceutical company Novo Nordisk. (Photo: James ...

Please watch the video at Investors.com - How Novo Nordisk, Wegovy And Ozempic Are Changing The Weight-Loss Game For Patients And Investors Late Tuesday, shares took a beating after a Cantor ...

The position in Novo Nordisk hindered returns as the company’s Wegovy obesity treatment missed revenue expectations due to a ...

If you said diabetes, you're right -- a new study finds diabetes costs $101 billion annually in diagnosis and treatment and ...

GLP-1 agonists – of which Novo Nordisk’s Ozempic and Wegovy (semaglutide) and Eli Lilly’s Mounjaro (tirzepatide) are the most ...

Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

Nov. 12—WATERTOWN — The Fort Drum Regional Health Planning Organization and North Country Health Compass Partners have ...